BioPlus Co., Ltd. acquired permission to manufacture veterinary medical devices

July 26, 2019

BioPlus Co., Ltd. received permission to manufacture veterinary medical devices from the Animal Drug Management Division on July 18, 2019. In addition, the approval of the 'Dressing, deep- cavity wound (adhesion inhibitor)' for animals was completed.

 In Korea, the number of pets is increasing due to the increase of single-person households and the aging population, and the market size is growing every year.

According to the KB Financial Holdings Research Institute's 2018 Survey on Pet Care, 25.1% of all households have pets, and the market for pet products grows at an average annual rate of 15%. Qualitative growth is expected.

As a result, BioPlus plans to actively expand the veterinary medical device market.

Please reload

BioPlus

Leader in HA filler manufacturing